Related Experiment Videos
Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing
Pete Anderson1, Maritza Salazar-Abshire
1Department of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA. pmanders@mdanderson.org
Current Oncology Reports
|October 17, 2006
Summary
Multimodality therapy, including chemotherapy and radiation, is essential for treating Ewing's sarcoma and osteosarcoma. This approach improves durable response and quality of life for patients with difficult-to-treat bone cancers.
Area of Science:
- Oncology
- Orthopedic Surgery
Background:
- Ewing's sarcoma and osteosarcoma often require complex treatment strategies.
- Surgery or chemotherapy alone yields limited success rates in curing these bone cancers.
- Multimodality treatment is crucial for achieving durable responses and preserving function.
Purpose of the Study:
- To discuss therapeutic principles for Ewing's sarcoma and osteosarcoma.
- To explore multimodality solutions for challenging bone cancer cases.
- To highlight the importance of quality of life and functional outcomes.
Main Methods:
- Review of therapeutic principles for Ewing's sarcoma and osteosarcoma.
- Discussion of surgical challenges in specific anatomical locations (spine, pelvis, etc.).
- Exploration of radiation and chemotherapy combinations, including novel agents like samarium and proton therapy.
Main Results:
- Multimodality therapy is superior to single-modality treatments for Ewing's sarcoma and osteosarcoma.
- Radiation combined with chemotherapy enhances local control and treatment effectiveness.
- Careful organization of patient care teams and resources is vital for successful multimodality treatment.
Conclusions:
- Effective treatment of Ewing's sarcoma and osteosarcoma necessitates a multimodality approach.
- Addressing difficult tumor locations and positive surgical margins requires integrated therapies.
- Optimizing patient outcomes involves balancing oncologic control with functional preservation and quality of life.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...